Rallybio Corporation (RLYB)
NASDAQ: RLYB · IEX Real-Time Price · USD
1.830
-0.070 (-3.68%)
May 2, 2024, 4:00 PM EDT - Market closed

Rallybio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current202320222021
Market Capitalization
6990210307
Market Cap Growth
--57.08%-31.34%-
Enterprise Value
-40-1942131
PE Ratio
-1.21-1.21-3.16-6.52
PB Ratio
0.650.851.241.75
P/FCF Ratio
-1.50-1.50-3.67-6.68
P/OCF Ratio
-1.50-1.50-3.67-6.73
EV/EBITDA Ratio
0.260.26-0.63-2.80
EV/EBIT Ratio
0.260.26-0.63-2.79
EV/FCF Ratio
0.320.32-0.73-2.86
Debt / Equity Ratio
0.000.000.00-
Debt / EBITDA Ratio
-0.01-0.01-0.01-
Debt / FCF Ratio
-0.01-0.01-0.01-
Quick Ratio
11.8711.8715.7326.76
Current Ratio
12.3912.3916.7127.61
Interest Coverage
----4700.30
Return on Equity (ROE)
-56.90%-56.90%-43.60%-80.40%
Return on Assets (ROA)
-53.40%-53.40%-41.10%-30.10%
Return on Capital (ROIC)
-74.06%-74.06%-39.96%-26.00%
Earnings Yield
-107.76%-82.55%-31.67%-15.34%
FCF Yield
-87.11%-66.73%-27.24%-14.96%
Buyback Yield / Dilution
-27.11%-27.11%-24.70%-46.76%
Total Shareholder Return
-27.11%-27.11%-24.70%-46.76%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).